1. Sikand VK, Halsey N, Krause PJ, et al. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial. Pediatrics. 2001;108:123-128.
2.
2. Centers for Disease Control and Prevention. Appendix methods used for creating a national lyme disease map. MMWR. 1999;48(RR07):21-24.
3.
3. Centers for Disease Control and Prevention. Lyme disease—United States, 1999. MMWR. 2001;50:181-185.
4.
4. Steere AC, Sikand VK, Meurice F, et al. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med1998;339:209-215.
5.
5. Parenti DL, Gillet M, Sennewal E, et al. A correlate of protection for LYMErix. Clin Infect Dis1998;27:1059-1059.
